Analyst Activity – Citigroup Initiates Coverage On NASDAQ:UBX – Unity Biotechnology (NASDAQ:UBX) With a Buy

ME Staff
-
0

Analyst Ratings For NASDAQ:UBX – Unity Biotechnology (NASDAQ:UBX)

Today, Citigroup initiated coverage on NASDAQ:UBX – Unity Biotechnology (NASDAQ:UBX) with a Buy with a price target of $32.00.

Some recent analyst ratings include

  • 5/29/2018-Citigroup initiated coverage with a Buy rating.
  • 5/29/2018-Morgan Stanley initiated coverage with a Overweight rating.
  • 5/29/2018-Goldman Sachs Group initiated coverage with a Neutral rating.


    Recent Trading Activity for NASDAQ:UBX – Unity Biotechnology (NASDAQ:UBX)
    Shares of NASDAQ:UBX – Unity Biotechnology closed the previous trading session at 13.40 up +0.40 3.08% with 13.899999618530273 shares trading hands.